Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)-Reference-Cited by-同舟云学术

Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)

Published:2016-05-30 Issue:6 Volume:97 Page:547-553
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Girolami Antonio¹,Cosi Elisabetta¹,Santarossa Claudia¹,Ferrari Silvia¹,Girolami Bruno²,Lombardi Anna Maria¹

Affiliation:

1. Department of Medicine; University of Padua Medical School; Padua Italy

2. Division of Medicine; Padua City Hospital; Padua Italy

Funder

Associazione Emofilia ed altre Coagulopatie delle Tre Venezie

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12767/fullpdf

Reference33 articles.

1. A new coagulation defect;Telfer;Br J Haematol,1956

2. Stuart clotting defect I. segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, Proconvertin, Factor VII) deficiency;Hougie;J Clin Invest,1957

3. Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state;Graham;J Clin Invest,1957

4. Uber einen neuartigen kongenitalen gerinnungs defect (Mangel an Stuart Faktor);Bachmann;Thromb Diath Haemorrh,1957

5. A “new” congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred;Girolami;Br J Haematol,1970

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor X deficiency and pregnancy;BMJ Case Reports;2024-07

2. Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe;Blood Coagulation & Fibrinolysis;2022-03

3. Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II);Hematology/Oncology Clinics of North America;2021-12

4. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency;Blood Reviews;2021-11

5. The slow but progressive disappearance of the patients with the Pro343Ser (FX Friuli) mutation;British Journal of Haematology;2020-08-04